COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 2933: Articles 29321-29330  | Next

High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads
Kalikiri, M. K. R., Hasan, M. R., Mirza, F., Xaba, T., Tang, P., Lorenz, S.
10.1101/2020.04.08.20055731 — Posted: 2020-04-11
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
Ye, L., Chen, X., Li, R., Pan, Z., Qian, C., Yang, Y., You, R., Zhao, J., Gao, L., Li, Z., Huang, Q., Xu, L., Tang, J., Tian, Q., Yao, W., Hu, L., Yan, X., Zhou, X., Liu, P., Wu, Y., Deng, K., Zhang, Z., Chen, Y., Qian, Z.
10.1101/2020.04.06.20055475 — Posted: 2020-04-11 Discussion: Offsite
Multi-route respiratory infection: when a transmission route may dominate
Gao, C. X., Li, Y., Wei, J., Cotton, S., Hamilton, M., Wang, L., Cowling, B. J.
10.1101/2020.04.06.20055228 — Posted: 2020-04-11
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
Borba, M., Val, F. d. A., Sampaio, V. S., Alexandre, M. A., Melo, G. C., Brito, M., Mourao, M., Brito Sousa, J. D., Baia-da-Silva, d., Guerra, M. V. F., Hajjar, L., Pinto, R. C., Balieiro, A., Naveca, F. G., Xavier, M., Salomao, A., Siqueira, A., Schwarzbolt, A., Croda, J. H. R., Nogueira, M. L., Romero, G., Bassat, Q., Fontes, C. J., Albuquerque, B., Daniel-Ribeiro, C., Monteiro, W., Lacerda, M., CloroCovid-19 Team
10.1101/2020.04.07.20056424 — Posted: 2020-04-11 Discussion: Onsite | Offsite
Development of a dual-gene loop-mediated isothermal amplification (LAMP) detection assay for SARS-CoV-2: A preliminary study
Butt, A. M., Siddique, S., An, X., Tong, Y.
10.1101/2020.04.08.20056986 — Posted: 2020-04-11
Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol
Izcovich, A., Ragusa, M., Sanguine, V., Tortosa, F., Espinosa, F., Agnoletti, C., Lavena Marzio, M. A., Bengolea, A., Saavedra, E., Catalano, H. N., Rada, G.
10.1101/2020.04.08.20056598 — Posted: 2020-04-11
A study of SARS-CoV-2 evolution in Italy: from early days to secondary effects after social distancing
Traini, M. C., Caponi, C., Ferrari, R., De Socio, G. V.
10.1101/2020.04.06.20055392 — Posted: 2020-04-11
Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences
Pei, S., Yuan, X., Zhimin Zhang, Z., Run Yao, R., Xie, Y., Minxue Shen, M., Bijuan Li, B., Chen, X., Yin, M.
10.1101/2020.04.07.20056440 — Posted: 2020-04-11
Alternative Qualitative Fit Testing Method for N95 Equivalent Respirators in the Setting of Resource Scarcity at the George Washington University
Provenzano, D., Rao, Y. J., Mitic, K., Obaid, S. N., Berger, J., Goyal, S., Loew, M. H.
10.1101/2020.04.06.20055368 — Posted: 2020-04-11
Association of County-Level Socioeconomic and Political Characteristics with Engagement in Social Distancing for COVID-19
Kavanagh, N. M., Goel, R. R., Venkataramani, A. S.
10.1101/2020.04.06.20055632 — Posted: 2020-04-11 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).